Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2018-09-17 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
2018年第五次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the resolutions from the 2018 fifth extraordinary general meeting of shareholders of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It details the meeting date, attendance, voting results, and legal witness statements. The content focuses on the voting outcomes and procedural compliance of the shareholders' meeting, specifically regarding a capital change and amendment to the company charter. It is not a full report but an official announcement of voting results from a shareholders' meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and it is not a full report or presentation, confirming it is a voting results announcement.
2018-09-17 Chinese
关于为关联方提供担保暨关联交易进展的补充公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding guarantees provided by the company to related parties, including descriptions of guarantee contracts, counter-guarantee contracts, and financial details of the related parties. It includes references to previous announcements and shareholder meeting approvals but does not contain financial statements or comprehensive financial performance data. The document is a regulatory announcement about related-party transactions and guarantees, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive content rather than just a notice of report availability. Therefore, the document fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2018-09-12 Chinese
关于召开2018年第五次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2018 fifth extraordinary general meeting of shareholders for the company 中源协和细胞基因工程股份有限公司. It includes information about the meeting date, voting methods (including online voting), meeting agenda, registration procedures, and other logistical details. There is no financial data, earnings information, or audit content. The document is not a report itself but a notice about the meeting and its arrangements. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document is also under 5,000 characters, consistent with a meeting announcement rather than a full report. Therefore, the correct classification is PSI.
2018-09-11 Chinese
2018年第五次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the 2018 fifth extraordinary shareholders meeting of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It includes the meeting agenda, voting procedures, and detailed proposals for changes in registered capital and amendments to the company charter. The document is a meeting material packet, not a report of financial results or audit. It is not a transcript or earnings release. It is not a notice of voting results but the materials for the meeting itself. The document length is about 3090 characters, which is relatively short and consistent with meeting materials. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual or Extraordinary General Meeting.
2018-09-07 Chinese
关于实际控制人增持公司股份计划的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the progress of a shareholding increase plan by the company's actual controller. It details the status of the planned share purchase, the risks involved, and the current holding percentage. There are no financial statements, earnings data, or detailed financial analysis. The document is short (879 characters) and serves as an update on a capital/financing activity related to shareholding increase. This fits the Capital/Financing Update (CAP) category rather than a full financial report or regulatory filing.
2018-09-07 Chinese
关于为关联方提供担保暨关联交易的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company 中源协和细胞基因工程股份有限公司 regarding the progress of guarantees provided to related parties and details of related party transactions. It includes specifics about guarantee contracts, amounts, counterparties, and approvals from shareholders' meetings. The document does not contain financial statements or detailed financial performance data but rather focuses on the status and terms of guarantees and related party transactions. It is not an annual report, interim report, earnings release, or audit report. It is also not a regulatory certification or a report publication announcement. The content fits best with a Capital/Financing Update (CAP) as it relates to guarantees and financing arrangements involving related parties and credit facilities. The document length is 2824 characters, which is relatively short but contains substantive information about financing guarantees rather than just an announcement of a report publication or a regulatory filing. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2018-08-31 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.